The TCR/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

The TCR/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia

Published:2019-12 Issue: Volume:74 Page:100638
ISSN:2212-4926
Container-title:Advances in Biological Regulation
language:en
Short-container-title:Advances in Biological Regulation

Author:

dos Santos Nuno R.,Ghysdael Jacques,Tran Quang Christine

Funder

Fundação para a Ciência e Tecnologia

European Regional Development Fund

Institut Curie, CNRS, Institut National du Cancer

Comité Essonne de la Ligue Contre le Cancer

INSERM

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment;Asnafi;Blood,2003

2. The genetics and mechanisms of T cell acute lymphoblastic leukaemia;Belver;Nat. Rev. Cancer,2016

3. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL);Bene;Leukemia,1995

4. Separately expressed T cell receptor alpha and beta chain transgenes exert opposite effects on T cell differentiation and neoplastic transformation;Brabb;Eur. J. Immunol.,1997

5. T cell receptor signalling networks: branched, diversified and bounded;Brownlie;Nat. Rev. Immunol.,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation;PLOS ONE;2024-06-26

2. Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL;Oncogene;2024-06-21

3. Transgenic αβ TCR tonic signaling is leukemogenic while strong stimulation is leukemia-suppressive;2024-01-22

4. Antigen receptor structure and signaling;Advances in Immunology;2023

5. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia;Biomarkers in Medicine;2021-06